Vonoprazan fumarate
CAS: 881681-01-2
Ref. 3D-FF102206
| 2g | 194.00 € | ||
| 5g | 310.00 € | ||
| 10g | 453.00 € | ||
| 25g | 647.00 € | ||
| 50g | 863.00 € |
Product Information
- 5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine (2E)-2-butenedioate
- 1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-, (2E)-2-butenedioate (1:1)
- 5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine (2E)-2-butenedioate (1:1)
- TAK 438 monofumarate
- Tak-438
- Takecab
- Vocinti
Vonoprazan is a prodrug that is converted to the active form, vonoprazan fumarate, in the gut. It has a chemical stability of over 2 weeks and can be administered as a single dose. Vonoprazan fumarate inhibits bacterial methyltransferase enzymes responsible for converting tetracycline into its active form. In combination with other antibiotics, this drug can be used to treat methicillin-resistant Staphylococcus aureus (MRSA) infections. Vonoprazan also inhibits drug efflux pumps and can reduce the stress on the liver caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Vonoprazan has been shown to have an effect on body mass index and increases weight loss in obese patients.
Chemical properties
Technical inquiry about: 3D-FF102206 Vonoprazan fumarate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
